Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Sriram Venneti(University of Michigan), Debra Hawes(Children's Hospital of Los Angeles), Michelle M. Kim(Cancer Research Center), Rajan Jain(NYU Langone Health), Abed Rahman Kawakibi(Cancer Research Center), Rodrigo T. Cartaxo(Cancer Research Center), Ziyun Xia(Cancer Research Center), Matthew Pun(Duke University), Sunjong Ji(Michigan Medicine), Hugh Garton(University of Michigan), Erik Peterson(Cancer Research Center), Dana Messinger(Cancer Research Center), Patrick Y. Wen(Dana-Farber Cancer Institute), Dustin Walling(Cancer Research Center), Isabel Arrillaga‐Romany(Harvard University), Benjamin M. Ellingson(University of California, Los Angeles), Nicole Shonka(University of Nebraska Medical Center), Heidi Baum(Cancer Research Center), Yoshie Umemura(Barrow Neurological Institute), Mateus Mota(University of Michigan), Minesh P. Mehta(Columbia University), Tingting Qin(Jiangsu University), Kévin Beccaria(Hôpital Necker-Enfants Malades), Rebecca A. Harrison(BC Cancer Agency), Rohinton S. Tarapore(Jazz Pharmaceuticals (United States)), Sebastian M. Waszak(European Molecular Biology Laboratory), Samuel Ramage(Cancer Research Center), Charles Burant(University of Michigan), John de Groot(University of California, San Francisco), Doured Daghistani, Akash Deogharkar(University of Michigan), Karthik Ravi(Mayo Clinic), Andrea Franson(Michigan Medicine), Timothy F. Cloughesy(University of California, Los Angeles), Maureen Kachman(University of Michigan), Matthew D. Hall(Baptist Hospital of Miami), Stefan R. Sweha, Tracy T. Batchelor(Brigham and Women's Hospital), Jonathan Schwartz(Cancer Research Center), Vishal John(Cancer Research Center), Pascale Varlet(Inserm), Andrew Chi(Therapeutics Clinical Research), Chan Chung(Daegu Gyeongbuk Institute of Science and Technology), Alyssa Waugh(Cancer Research Center), Ashley Sumrall(Levine Cancer Institute), Nicholas Butowski(University of California, San Francisco), Sophie L. Mottl(Cancer Research Center), Peter Sajjakulnukit(University of Michigan), Yujie J. Ding(Tianjin University of Traditional Chinese Medicine), Anna Schwendeman(University of Michigan)
Cited by 2
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.5k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k